GleanMark

LIFE EXPANDER Trademark

LIFE EXPANDER is a USPTO trademark filed by Nanobiotix. Status: Registered.

Trademark Facts

MarkLIFE EXPANDER
Serial Number99180580
Registration Number8174087
StatusRegistered
Filing Date2025-05-12
Registration Date2026-03-17
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT)
OwnerNanobiotix
Attorney of RecordArturo Perez Guerrero
Prosecution Events16
Latest EventR.PR on 2026-03-17

Goods & Services

Pharmaceutical products, medical and veterinary preparations; Fillings for teeth; Materials for making dental impressions; Chemical-pharmaceutical products; Health products, namely, pharmaceutical products, medical and veterinary preparations; Radiological contrast substances for medical use; Chemical reagents for medical use; Biological reagents for medical use; Chemical preparations for medical or pharmaceutical use; Diagnostic preparations for medical purposes; Medicines for human medicine; Products for medical use, namely for the diagnosis and treatment of tumors; Medical apparatus and instruments for use in surgery; Medical instruments, namely, orthopedic apparatus and instruments; Prosthetics; Artificial implant prostheses; Radiotherapy apparatus; Surgical apparatus and instruments for medical use; Apparatus for medical diagnosis; Surgical and medical devices and instruments; Biological research; Radiobiology research; Research in nanoscience and nanotechnology, particularly applied to medicine; Scientific research; Computer software design; Computer design services; Scientific and technological services as well as research and design services, particularly in the field of nanomedicine namely nanotechnology applied to medicine; Technical research; Information technology consulting

Recent Prosecution Activity

DateDocumentType
2026-01-27OG Publication ConfirmationPB3
2026-01-21Notice of PublicationPB1
2026-01-21Notification of Notice of PublicationEB4
2026-01-02TRAM Snapshot of App at Pub for OppostnPST
2025-12-21Amendment and Mail Process CompleteAMC
2025-12-21Response to Office ActionROA

Related